Eyewitnesses to history and participants as well^†

• Page: 1897
• First Published: 02 December 2011

Surveillance for hepatocellular carcinoma: A standard of care, not a clinical option^†‡

• Pages: 1898-1900
• First Published: 02 December 2011

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells^†‡

• Pages: 1901-1912
• First Published: 02 December 2011

Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures^†

• Pages: 1913-1923
• First Published: 02 December 2011

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations^†‡

• Pages: 1924-1935
• First Published: 02 December 2011

Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus^†

• Pages: 1936-1946
• First Published: 02 December 2011

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry^†‡

• Pages: 1947-1955
• First Published: 02 December 2011

Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1^†‡§

• Pages: 1956-1965
• First Published: 02 December 2011

Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking^†‡

• Pages: 1966-1974
• First Published: 02 December 2011

Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice^†‡

• Pages: 1975-1986
• First Published: 02 December 2011

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities^†‡

• Pages: 1987-1997
• First Published: 02 December 2011

Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?^†‡

• Pages: 1998-2004
• First Published: 02 December 2011

Radiofrequency ablation of high-grade dysplastic nodules^†

• Pages: 2005-2011
• First Published: 02 December 2011

HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells^†‡

• Pages: 2012-2024
• First Published: 02 December 2011

The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma^†‡

• Pages: 2025-2035
• First Published: 02 December 2011

Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice^†‡

• Pages: 2036-2047
• First Published: 02 December 2011

Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none?^†‡

• Pages: 2048-2054
• First Published: 02 December 2011

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy^†‡

• Pages: 2055-2063
• First Published: 02 December 2011

Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma^†

• Pages: 2064-2075
• First Published: 02 December 2011

Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells^†‡

• Pages: 2076-2088
• First Published: 02 December 2011

MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint^†‡

• Pages: 2089-2098
• First Published: 02 December 2011

Seasonal variation in the patient diagnosis of primary biliary cirrhosis: Further evidence for an environmental component to etiology^†‡

• Pages: 2099-2103
• First Published: 02 December 2011

Effects of bilirubin and sera from jaundiced patients on osteoblasts: Contribution to the development of osteoporosis in liver diseases^†

• Pages: 2104-2113
• First Published: 02 December 2011

Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival^†‡

• Pages: 2114-2124
• First Published: 02 December 2011

Tenascin-C: A novel mediator of hepatic ischemia and reperfusion injury^†‡

• Pages: 2125-2136
• First Published: 02 December 2011

Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling^†

• Pages: 2137-2148
• First Published: 02 December 2011

Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein–mediated activation^†‡§¶

• Pages: 2149-2158
• First Published: 02 December 2011

Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets^†‡§

• Pages: 2159-2172
• First Published: 02 December 2011

Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta^{† ‡}

• Pages: 2173-2184
• First Published: 02 December 2011

An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in mice^†‡

• Pages: 2185-2197
• First Published: 02 December 2011

A polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesis^{† ‡}

• Pages: 2198-2207
• First Published: 02 December 2011

Activation of liver X receptor increases acetaminophen clearance and prevents its toxicity in mice^†‡

• Pages: 2208-2217
• First Published: 02 December 2011

Hepatitis E^†‡

• Pages: 2218-2226
• First Published: 02 December 2011

Magnetic resonance imaging of focal liver lesions: Approach to imaging diagnosis^†

• Pages: 2227-2237
• First Published: 02 December 2011

Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques^†‡

• Pages: 2238-2244
• First Published: 02 December 2011

Human immunodeficiency virus and liver disease forum 2010: Conference proceedings^†‡

• Pages: 2245-2253
• First Published: 02 December 2011

Boceprevir^†

• Pages: 2254-2258
• First Published: 02 December 2011

An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community^†

• Pages: 2259-2261
• First Published: 02 December 2011

Hepatic endoplasmic reticulum stress in obesity: Deeper insights into processes, but are they relevant to nonalcoholic steatohepatitis?^†

• Pages: 2261-2266
• First Published: 02 December 2011

Phosphatidylcholines as regulators of glucose and lipid homeostasis: Promises and potential risks^†

• Pages: 2266-2268
• First Published: 02 December 2011

Infiltrating monocytes versus resident kupffer cells: Do alternatively activated macrophages need to be targeted alternatively?^†‡

• Pages: 2269-2271
• First Published: 02 December 2011

Peribiliary cysts^†

• Pages: 2272-2273
• First Published: 02 December 2011

Clusters of differentiation 24 polymorphism and hepatocellular carcinoma^†

• Pages: 2274-2275
• First Published: 02 December 2011

Reply^†

• Page: 2275
• First Published: 02 December 2011

Idiopathic noncirrhotic intrahepatic portal hypertension is an ongoing problem in India^†‡

• Pages: 2275-2276
• First Published: 02 December 2011

Reply^†

• Page: 2276
• First Published: 02 December 2011

I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population^†

• Page: 2276
• First Published: 02 December 2011

Noninvasive assessment of liver fibrosis: The clinical context and question are important^†

• Page: 2277
• First Published: 02 December 2011

Targeting the renin-angiotensin system: Potential beneficial effects of the angiotensin II receptor blockers in patients with nonalcoholic steatohepatitis^†‡

• Pages: 2277-2278
• First Published: 02 December 2011

Metabolic Syndrome Is Also a Risk Factor for Primary Liver Cancer in Patients Younger than 65 Years of Age?^†

• Pages: 2278-2279
• First Published: 02 December 2011

Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4^†

• Page: 2279
• First Published: 02 December 2011

• Page: 2280
• First Published: 02 December 2011

• Page: 2280
• First Published: 02 December 2011

• Page: 2280
• First Published: 02 December 2011

• Page: 2280
• First Published: 02 December 2011

• Pages: 2280-2281
• First Published: 02 December 2011

• Pages: 2281-2282
• First Published: 02 December 2011

• Pages: I-V
• First Published: 02 December 2011